Skip to main content
Clinical Trials/DRKS00033983
DRKS00033983
Completed
Not Applicable

Perioperative antibiotic prophylaxis in patients with morbid obesity undergoing laparoscopic sleeve gastrectomy in a certified center of excellence for obesity and metabolic surgery

St. Josef KH Bad Driburg KHWE0 sites525 target enrollmentApril 8, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
T98.3
Sponsor
St. Josef KH Bad Driburg KHWE
Enrollment
525
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 8, 2024
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
St. Josef KH Bad Driburg KHWE

Eligibility Criteria

Inclusion Criteria

  • The study included adult patients aged 18 and over with morbid obesity who underwent LSG in the Competence Center for Bariatric Surgery in Bad Driburg between January 1, 2018 and December 31, 2021 for the purpose of weight loss, regardless of gender, BMI and weight or obesity\-related comorbidities.

Exclusion Criteria

  • Patients who have already taken antibacterial substances for purposes other than PAP pre\- or perioperatively or who stopped taking them more than 7 days preoperatively
  • Patients who have evidence of colonization with germs with known resistance to antibiotics (e.g. MRSA or MRGN)
  • Patients with immune deficiency
  • Patients in whom LSG was undertaken as a bariatric revision procedure (redo operations, e.g. gastric band removal with LSG).
  • Patients who have experienced other complications not related to surgical infection causing an increase in inflammatory parameters or antibiotic therapy and significantly alter the standardized course.

Outcomes

Primary Outcomes

Not specified

Similar Trials